These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34407729)

  • 1. Evaluation of the of the efficacy of Fractional Erbium-Doped Yttrium Aluminum Garnet Laser-Assisted Drug Delivery of Kojic Acid in the Treatment of Melasma; A split face, comparative clinical study.
    Al-Dhalimi MA; Yasser RH
    J Cosmet Laser Ther; 2021 May; 23(3-4):65-71. PubMed ID: 34407729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the tolerance and efficacy of laser-assisted delivery of tranexamic acid, niacinamide, and kojic acid for melasma: A single center, prospective, split-face trial.
    Park SJ; Park JW; Seo SJ; Park KY
    Dermatol Ther; 2022 Mar; 35(3):e15287. PubMed ID: 34962047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma.
    Badawi AM; Osman MA
    Clin Cosmet Investig Dermatol; 2018; 11():13-20. PubMed ID: 29379308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A split-face comparison of fractional erbium: YAG laser plus Kligman's formula vs. Kligman's formula monotherapy for facial melasma.
    Nasimi M; Ghiasi M; Lajevardi V; Nasiri F; Shakoei S
    Arch Dermatol Res; 2022 Oct; 314(8):791-797. PubMed ID: 34705101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients.
    Yue B; Yang Q; Xu J; Lu Z
    Lasers Med Sci; 2016 Nov; 31(8):1657-1663. PubMed ID: 27450275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial.
    Mokhtari F; Bahrami B; Faghihi G; Asilian A; Iraji F
    J Dermatolog Treat; 2022 Aug; 33(5):2475-2481. PubMed ID: 34387527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
    Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
    Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
    Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
    Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma.
    Abdel-Raouf Mohamed H; Ali Nasif G; Saad Abdel-Azim E; Abd El-Fatah Ahmed M
    J Cosmet Dermatol; 2019 Apr; 18(2):517-523. PubMed ID: 30146730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, Double-Blind, Split-Face Study Evaluating Fractional Ablative Erbium:YAG Laser-Mediated Trans-Epidermal Delivery of Cosmetic Actives and a Novel Acoustic Pressure Wave Ultrasound Technology for the Treatment of Skin Aging, Melasma, and Acne Scars.
    Alexiades M
    J Drugs Dermatol; 2015 Nov; 14(11):1191-8. PubMed ID: 26580866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining Low Power Fractional CO
    Esmat S; Z Elramly A; Shahin D; Hilal RF
    Lasers Surg Med; 2021 Dec; 53(10):1325-1340. PubMed ID: 34164829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of combined fractional CO
    Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
    Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fractional erbium:YAG laser-assisted tranexamic acid delivery alone and in combination with oral tranexamic acid in melasma.
    Botsali A; Esme P; Erbil H; Caliskan E
    Lasers Med Sci; 2022 Sep; 37(7):2823-2830. PubMed ID: 35347552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
    Ustuner P; Balevi A; Ozdemir M
    J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A split face comparative study between intradermal tranexamic acid and Erbium-YAG laser in treatment of melasma.
    Otb S; Shaarawy E; Sadek A; Abdallah N; Agamia N; Soliman M; Tawfik AA
    J Dermatolog Treat; 2022 Feb; 33(1):555-559. PubMed ID: 32420770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
    Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS
    Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
    Geddes ER; Stout AB; Friedman PM
    Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Q-Switched Nd:YAG and Fractional Erbium:YAG Lasers in Treatment of Melasma: A Randomized Controlled Clinical Trial.
    Alavi S; Abolhasani E; Asadi S; Nilforoushzadeh M
    J Lasers Med Sci; 2017; 8(1):1-6. PubMed ID: 28912936
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
    Jeong SY; Shin JB; Yeo UC; Kim WS; Kim IH
    Dermatol Surg; 2010 Jun; 36(6):909-18. PubMed ID: 20384749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Split-Face Comparison of the Combined Er-YAG Laser and Hydroquinone 4% With Hydroquinone 4% Alone in the Treatment of Melasma in Iranian Patients: A Prospective, Interventional Case Study.
    Namazi N; Hesami A; Ketabi Y
    J Lasers Med Sci; 2020; 11(1):70-73. PubMed ID: 32099630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.